Skip to content

Penn State Health Metabolic Dysfunction-Associated Steatohepatitis (MASH) Day

Thursday, June 12, 2025

University Conference Center

Penn State Health Milton S. Hershey Medical Center and Penn State College of Medicine
30 Conference Dr.
Hershey, PA 17033

More about the location

Select this button to navigate the sections of this page

Conference ID

A7073

Partner/Sponsor

Fatty Liver Program, Penn State Health

Division of Gastroenterology and Hepatology, Penn State Health

Purpose/Overview

This educational opportunity is being offered to foster a multidisciplinary, evidence-based approach to MASLD/MASH by enhancing collaboration, translating research into clinical practice, and promoting patient-centered strategies for effective disease management.

Overall Objectives

  • Discuss knowledge-sharing among providers to improve the multidisciplinary approach to MASLD/MASH diagnosis, management, and treatment.
  • Describe the latest research on lifestyle interventions, pharmacotherapy, and emerging therapies for MASLD/MASH, including actionable strategies to implement in patient care.
  • Explain strategies for engaging patients in sustainable lifestyle modifications, including diet, exercise, and behavioral interventions to improve long-term metabolic and liver health outcomes.

Agenda

  • 7 a.m. | Registration and Continental Breakfast
  • 7:30 a.m. | Product Theater
    TBD
  • 8:30 a.m. | Welcome and Opening Remarks
    Kofi Clarke, MD, FACP, FRCP (Lond.)
  • 8:35 a.m. | Introduction to Penn State Health MASH Day
    Jonathan G. Stine, MD MSc, FACP
  • Session 1: Epidemiology and Clinical Perspectives in MASLD

    Moderators: Elizabeth Stonesifer, MD & Justin Tondt, MD

  • 8:40 a.m. | The Burden of MASLD and Implications for Global Health
    Karen Krok, MD
  • 9 a.m. | MASLD and Sleep Apnea: The Role of Hypoxia
    Vinciya Pandian, PhD
  • 9:20 a.m. | Metabolic Syndrome and Cardiovascular Disease: The Liver Connection
    Jennifer McCall-Hosenfeld, MD, MSc
  • 9:40 a.m. | Conditional Approval of Resmetirom: How Does This Change My Practice?
    Ian Schreibman, MD
  • 10 a.m. | Panel Q&A: Morning Faculty
  • 10:20 a.m. | Break and Exhibits
  • Session 2: | Lifestyle and Bariatric Interventions in MASLD

    Moderators: Karen Krok, MD & Yaron Rotman, MD

  • 10:40 a.m. | Advances in Endo-Bariatric Therapies for MASLD
    Hadie Razjouyan, MD
  • 11 a.m. | Time-Restricted Eating and MASLD
    Jessica Dahmus, MD
  • 11:20 a.m. | Bariatric Surgery as a Treatment for MASLD/MASH
    Ann Rogers, MD
  • 11:40 a.m. | Exercise and Muscle-Liver Axis Dysfunction in MASLD
    Hannah Mohr, MS
  • Noon | Panel Q&A: Morning Faculty
  • Session 3: The Patient Voice in MASLD

    Moderator: Jonathan G. Stine, MD MSc, FACP

  • 12:30 p.m. | Lunch and Patient Panel
  • Session 4: Special Populations and Emerging Trends in MASLD

    Moderators: Ian Schreibman, MD & Jonathan G. Stine, MD MSc, FACP

  • 1:30 p.m. | MetALD: Blurring the Lines
    Elizabeth Stonesifer, MD
  • 1:50 p.m. | Keynote: Integrating Genomics and Precision Medicine in MASLD Care
    Yaron Rotman, MD
  • 2:30 p.m. | Panel Q&A: Morning Faculty
  • 2:50 p.m. | Break and Exhibits
  • Session 5: Closing Session: Future Directions in MASLD Research, Clinical Care and Policy

    Moderators: Jennifer McCall-Hosenfeld, MD, MSc & Hannah Mohr, MS

  • 3:20 p.m. | Community-Based Models for MASLD Management
    Todd Felix, MD
  • 3:40 p.m. | To GLP-1 or Not? That is the question
    Justin Tondt, MD
  • 4 p.m. | Call to Action: Collaboration in MASLD Research and Care Through Building A Multidisciplinary Program
    Jonathan G. Stine, MD MSc, FACP
  • 4:20 p.m. | Final Q&A and Closing Remarks
  • 4:30 p.m. | Adjournment

Committee

Kofi Clarke, MD, FACP, FRCP (Lond.)
Professor of Medicine
Chief, Division of Gastroenterology and Hepatology
Penn State Health/Penn State College of Medicine

Karen Krok, MD
Department of Medicine – Professor and Vice Chair for Clinical Affairs
Division of Gastroenterology and Hepatology – Director of Hepatology
Penn State Cancer Institute

Jonathan G. Stine, MD MSc, FACP
Associate Professor of Medicine and Public Health Sciences
Fatty Liver Program Director, Penn State Health
Research Director, Penn State Health Liver Center

Presenters

Kofi Clarke, MD, FACP, FRCP (Lond.)
Professor of Medicine
Chief, Division of Gastroenterology & Hepatology
Penn State Health/Penn State College of Medicine

Jessica Dahmus, MD
Department of Medicine – Assistant Professor
Division of Gastroenterology and Hepatology

Todd Felix, MD
Department of Family and Community Medicine – Associate Professor and Vice Chair, Quality and Population Health
Penn State Cancer Institute
Cancer Institute, Cancer Control

Karen Krok, MD
Department of Medicine – Professor and Vice Chair for Clinical Affairs
Division of Gastroenterology and Hepatology – Director of Hepatology
Penn State Cancer Institute

Jennifer McCall-Hosenfeld, MD, MSc
Penn State College of Medicine – Associate Dean for Faculty and Professional Development
Department of Medicine – Professor and Kenneth V. and Eleanor M. Hatt Faculty Fellow in Internal Medicine
Division of General Internal Medicine
Department of Public Health Sciences – Professor

Hannah Mohr, MS
Graduate Education – Graduate Assistant (Research)

Vinciya Pandian, PhD
Ross and Carol Nese College of Nursing – Professor

Hadie Razjouyan, MD
Department of Medicine – Assistant Professor
Division of Gastroenterology and Hepatology

Ann Rogers, MD
Department of Surgery – Professor and Vice Chair for Faculty Development
Division of Minimally Invasive Surgery/Bariatrics

Yaron Rotman, MD
Liver and Energy Metabolism Section, Liver Diseases Branch – Section Chief
Clinical Research Section, Liver Diseases Branch – Senior Investigator
National Institutes of Health

Ian Schreibman, MD
Department of Medicine – Professor
Division of Gastroenterology and Hepatology
Penn State Cancer Institute

Jonathan G. Stine, MD MSc, FACP
Associate Professor of Medicine and Public Health Sciences
Fatty Liver Program Director, Penn State Health
Research Director, Penn State Health Liver Center

Elizabeth Stonesifer, MD
Department of Medicine – Assistant Professor

Justin Tondt, MD
Department of Family and Community Medicine – Assistant Professor
Department of Public Health Sciences – Assistant Professor

Credit

AMA

Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 6 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses Using AMA Credit

Nurses will receive a certificate from Penn State College of Medicine verifying their participation in up to 6 hours of approved continuing medical education. Continuing education activities which are approved by accredited institutions of higher education and that are relevant to patient care or professional nursing meet the requirements of mandatory continuing education for registered nurses in Pennsylvania, as required by the Pennsylvania State Board of Nursing. The Board of Nursing recommends that nurses retain their certificates for a period of at least five years. Additional information is available through the State Board of Nursing.

Fees

There is no fee, but registration is required.

Evaluation

A completed evaluation is required in order to receive a certificate for attending this activity. Please complete and submit the evaluation within the specified time frame.

Cancellations

The University reserves the right to cancel or postpone any course or activity because of insufficient enrollment or other unforeseen circumstances. If a program is canceled or postponed, the University will refund any program registration fees paid but cannot be held responsible for any related costs, charges or expenses, including cancellation/change charges assessed by airlines or travel agencies.

Program registrants who are experiencing illness or have been exposed to anyone who is ill should contact the Continuing Education office before attending any in-person activities.

Changes

Content and speakers for all programs are subject to change. Registrants will be notified of any significant updates.

COVID-19

On-campus educational activities provided by Penn State College of Medicine Continuing Education are required to follow healthcare facility guidelines. Off-campus events provided by Penn State College of Medicine Continuing Education follow the COVID-19 requirements of that venue. We ask that all participants respect that some attendees may still choose to wear masks for activities. Check the venue website for the latest requirements and recommendations. Please do not attend this activity if you have symptoms or have been exposed to someone with COVID-19. By attending the activity, you attest that you do not have any symptoms suggestive of COVID-19, which may include fever, cough, shortness of breath, sore throat, loss of taste, loss of smell or any other sign of illness.

Access (ADA)

Penn State encourages people with disabilities to participate in its programs and activities. Participants who anticipate needing any type of special accommodation or who have questions about the physical access provided should contact the Continuing Education office at least one week in advance of participation or visit.

Disclosure and Conflict of Interest (COI and Educational Balance)

It is Penn State policy to ensure balance, independence, objectivity and scientific rigor in all educational activities. Penn State has a process in place to mitigate any relevant financial relationships with commercial companies disclosed by faculty, course directors and planning committee members. Complete disclosure information will be provided to participants at the beginning of the activity.

University Nondiscrimination Policy

This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission and employment without regard to personal characteristics not related to ability, performance or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment or retaliation against faculty, staff or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; 814-863-0471 (TTY). US M.Ed. A7073

Jump to ...